Latest News

Medicine Channels: Cardiovascular Health, Neuro, Smoking Smoking, Smoking Cessation, Aneurysm, aneurysm recurrence, Endovascular, Endovascular Aneurysm Repair, Neurosurgery, interventional care	Smoking Raises Risk of Aneurysm Recurrence After Endovascular Treatment Open in New Tab | View | Comment A history of smoking significantly increases the chance that survivors will experience recurrence of a brain aneurysm, according to a University of Michigan study. Researchers say it’s a serious reminder about the importance of smoking cessation, especially for patients who undergo endovascular aneurysm treatment.	Released: 16-Aug-2017 5:05 PM EDT Michigan Medicine - University of Michigan
Medicine Channels: Children's Health, Infectious Diseases, Public Health Probiotic, Probiotics, probiotic therapy, probiotic treatment, Sepsis, sepsis prevention, Blood Infection, Blood Infections, Pediactrics, Public Health, public health and medicine , public health care, public health and safety	Study Shows Probiotics Can Prevent Sepsis in Infants Open in New Tab | View | Comment A research team at the University of Nebraska Medical Center College of Public Health has determined that a special mixture of good bacteria in the body reduced the incidence of sepsis in infants in India by 40 percent at a cost of only $1 per infant.	Released: 16-Aug-2017 5:05 PM EDT University of Nebraska Medical Center (UNMC)
Medicine Channels: Cancer, Oral Health NYU Dentistry, Oral Cancer, Bluestone Center for Clinical Research, NIH Award	NYU Dental Researchers Awarded NIH Grant for Microbiome Research to Identify Biomarkers for Tongue Cancer Open in New Tab | View | Comment The research focuses on the oral microbiome and disruptions in its normal balance, using next-generation sequencing, new molecular technologies which now permit far more comprehensive analyses of the bacterial community in the mouth. Researchers aim to learn how to diagnose aggressive cancers earlier, modulate the microbiome, and prevent or slow the oral cancer progression.	Released: 16-Aug-2017 4:55 PM EDT New York University
Medicine Channels: Addiction, Drugs and Drug Abuse, Neuro, Pain, Public Health, Race Migraine, Headache, Disparities, disparities in healthcare, Neuro, Neurology, Opioids, opioid prescribing	Study: Opioids Overused in Migraine Treatment, Regardless of Race Open in New Tab | View | Comment African-Americans are more likely to experience debilitating migraine headaches than whites, but a new study probing the issue found no evidence of racial disparities in treatment practices. Instead, researchers report a different finding that affects everyone: opioid overuse.	Released: 16-Aug-2017 4:55 PM EDT Michigan Medicine - University of Michigan
Medicine Channels: Addiction, AIDS and HIV, Drugs and Drug Abuse, Public Health, Substance Abuse Health, Disease Development, opoid addiction, HIV, Hepatitis C	WVU Researchers, Health Professionals Lead New Effort to Prevent HIV and Hepatitis C Outbreaks Related to Opioid Epidemic Open in New Tab | View | Comment When communities face epidemics of drug abuse, a wave of infectious diseases often follows, including hepatitis and HIV. A new federally-funded program in southern West Virginia, led by West Virginia University, will seek to interrupt that cycle.	Released: 16-Aug-2017 4:55 PM EDT West Virginia University
Medicine Channels: Addiction, Drugs and Drug Abuse, Pain, Pharmaceuticals, Public Health UAMS, University Of Arkansas For Medical Sciences, Bradley Martin, Dr. Bradley Martin, UAMS College of Pharmacy, The Journal Of Pain, Anuj Shah, Corey Hayes, Pharm.D., Division of Pharmaceutical Evaluation and Policy, logn-term opioid use, Opioids, opioid abuse	Day-Supply of Prescribed Opioids Most Decisive Factor in Likelihood of Long-Term Use Open in New Tab | View | Comment The single biggest factor determining whether a patient is likely to use opioids long term may be the number of days’ supply initially prescribed, according to a study by UAMS researchers.	Released: 16-Aug-2017 4:55 PM EDT University of Arkansas for Medical Sciences
Medicine Channels: Public Health, Respiratory Diseases and Disorders	EMBARGOED A reporter's PressPass is required to access this story until the embargo expires on 16-Aug-2017 6:30 PM EDT	Embargo will expire: 16-Aug-2017 6:30 PM EDT Released to reporters: 16-Aug-2017 4:55 PM EDT
Life Law and Public Policy Channels: Civil Liberties, Government/Law, U.S. National Security, U.S. Politics Charlottesville, First Amendment, Constitution, Free Speech, Nazis	WashU Expert: The First Amendment and the Nazi flag Open in New Tab | View | Comment In the wake of the Aug. 12 confrontations between protesters and counter-protesters in Charlottesville, Virginia, some progressives are calling for legal restrictions on the display of the Nazi flag. These arguments are entirely understandable, but they often misapply existing First Amendment law, and they suppress free speech values that progressives — more than anyone else — should want to defend, says a Constitutional law expert at Washington University in St.	Released: 16-Aug-2017 4:30 PM EDT Washington University in St. Louis
Science Channels: Education, STEM Education Energy, Biofuels, Energy Sources, Renewable Energy, Bioenergy, energy usage, Energy Storage, Environment, Environmental science & technology, Ecology, Sensors & detectors, Chemical sciences & engineering , Materials Science, Nanoscience, Mathematics, computing, & computer science, networking & data management, Community, Education, Undergraduate Students, Internships, Science Careers in Search of Women, General Argonne Information	Young Minds Take the Stage at Argonne Open in New Tab | View | Comment Argonne’s Learning on the Lawn celebration capped 10 weeks of intense discoveries and experimentation for 90 students, led by luminaries from across the laboratory – from nuclear engineers to biologists to experts in exascale computing, systems that will be 50+ times quicker than today’s supercomputers.	Released: 16-Aug-2017 4:05 PM EDT Argonne National Laboratory
Medicine Channels: Cancer, Cell Biology, Immunology, Respiratory Diseases and Disorders, All Journal News pembrolizumab, Small Cell Lung Cancer, SCLC, Immunotherapy, Rutgers University, New Jersey	Favorable Safety Profile Seen in Immunotherapy Drug in Aggressive Form of Lung Cancer Open in New Tab | View | Comment The immunotherapy drug pembrolizumab has demonstrated a favorable safety profile and “promising durable clinical activity” in pretreated patients who exhibit high levels of the PD-L1 protein in advanced stages of small cell lung cancer. That is according to data from a phase 1b clinical trial conducted by Rutgers Cancer Institute of New Jersey investigators and colleagues at centers around the world.	Embargo expired: 16-Aug-2017 4:00 PM EDT Released: 16-Aug-2017 9:50 AM EDT Rutgers Cancer Institute of New Jersey